SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-010099
Filing Date
2024-04-03
Accepted
2024-04-03 17:30:27
Documents
1
Period of Report
2023-04-01

Document Format Files

Seq Description Document Type Size
1 form4-04032024_050412.html 4  
1 form4-04032024_050412.xml 4 4407
  Complete submission text file 0001415889-24-010099.txt   6067
Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Issuer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 L3 20100
Business Address
Bashan Dror (Reporting) CIK: 0001781450 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33357 | Film No.: 24820298